Structural Characterization of a Macrocyclic Peptide Modulator of the PD-1/PD-L1 Immune Checkpoint Axis

Схожие документы

• Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies
  по: Ismael Rodriguez, и др.
  Опубликовано: (2023-09-01)
• Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma
  по: Kazuhiko Hashimoto, и др.
  Опубликовано: (2020-07-01)
• Peptide-based inhibitors targeting the PD-1/PD-L1 axis: potential immunotherapeutics for cancer
  по: Magdalena Bojko, и др.
  Опубликовано: (2024-04-01)
• Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
  по: Ruiting Li, и др.
  Опубликовано: (2021-06-01)
• Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges
  по: Sadique A. Javed, и др.
  Опубликовано: (2024-04-01)